Cynomolgus OLR1 / LOX1 Protein (His Tag)
OLR1
- 100ug (NPP1852) Please inquiry
Catalog Number | P90155-C07H |
---|---|
Organism Species | Cynomolgus |
Host | Human Cells |
Synonyms | OLR1 |
Molecular Weight | The recombinant heterodimer of cynomolgus OLR1 comprises 233 amino acids and has a calculated molecular mass of 26.9 KDa. The apparent molecular mass of the protein is approximately 37 KDa respectively in SDS-PAGE. |
predicted N | His |
SDS-PAGE | |
Purity | > 95 % as determined by SDS-PAGE |
Protein Construction | A DNA sequence encoding the cynomolgus OLR1 (G7PJT2) (Ser61-Gln273) was expressed with a polyhistide tag at the N-terminus. |
Bio-activity | |
Research Area | Signaling |Signal Transduction |Cytoskeleton / ECM |Cell Adhesion |Lectin |C-tyep lectin | |
Formulation | Lyophilized from sterile PBS, pH 7.4 1. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA. |
Background | Oxidized low-density lipoprotein receptor 1 (Ox-LDL receptor 1 or OLR1), also known as lectin-type oxidized LDL receptor 1 (LOX1), is a receptor protein that belongs to the C-type lectin superfamily. LOX1 is a multi-ligand receptor originally identified as the endothelial oxidized LDL receptor. OLR1 / LOX1 was isolated from an aortic endothelial cell, and recently it has been discovered in macrophages and vascular smooth muscle cells in artery vessels. The expression of LOX1 is inducted by inflammatory stimuli and oxidative stimuli. This protein binds, internalizes and degrades oxidized low-density lipoprotein. LOX1 may play an important role in the progression of vulnerable carotid plaque and might regulate vulnerable plaque formation in cooperation with MMPs and TIMP-2. In clinical, LOX1 is thought to be involved in the development of atherosclerotic lesions. |
Reference |